戻る Agenda
BRINGING CLINICAL AND REGULATORY TOGETHER
Speaker(s)
Marta Arias-Salgado
Merck Sharp & Dohme, Netherlands
Executive Director; Global Clinical Trial Operation
Karen Roy, MPHARM
Phlexglobal, United Kingdom
Chief Strategy Officer
Peter Schueler, DrMed, MD
ICON plc (CRO), Germany
Senior Vice President, Drug Development Neurosciences
Hans van Bruggen, MSC
Celegence, United States
Director of Regulatory Affairs